- Report
- July 2024
- 155 Pages
Global
From €3012EUR$3,400USD£2,579GBP
€3766EUR$4,250USD£3,223GBP
- Report
- August 2025
- 145 Pages
Global
From €3500EUR$3,950USD£2,996GBP
- Report
- October 2023
- 143 Pages
Global
From €3943EUR$4,450USD£3,375GBP
- Report
- March 2026
- 150 Pages
Germany
From €4297EUR$4,850USD£3,678GBP
- Report
- March 2026
- 150 Pages
Canada
From €4297EUR$4,850USD£3,678GBP
- Report
- March 2026
- 150 Pages
China
From €4297EUR$4,850USD£3,678GBP
- Report
- March 2026
- 150 Pages
India
From €4297EUR$4,850USD£3,678GBP
- Report
- March 2026
- 150 Pages
Germany
From €4297EUR$4,850USD£3,678GBP
- Report
- March 2026
- 150 Pages
Canada
From €4297EUR$4,850USD£3,678GBP
- Report
- March 2026
- 150 Pages
China
From €4297EUR$4,850USD£3,678GBP
- Report
- March 2026
- 150 Pages
India
From €4297EUR$4,850USD£3,678GBP
- Report
- August 2025
- 150 Pages
Global
From €4297EUR$4,850USD£3,678GBP
- Report
- August 2025
- 150 Pages
Global
From €4297EUR$4,850USD£3,678GBP
- Report
- August 2025
- 150 Pages
Global
From €4297EUR$4,850USD£3,678GBP
- Report
- August 2025
- 150 Pages
Global
From €4297EUR$4,850USD£3,678GBP
- Report
- July 2025
- 150 Pages
Global
From €4297EUR$4,850USD£3,678GBP
- Report
- July 2025
- 150 Pages
Global
From €4297EUR$4,850USD£3,678GBP
- Report
- June 2025
- 150 Pages
Global
From €4297EUR$4,850USD£3,678GBP
- Report
- June 2025
- 150 Pages
Global
From €4297EUR$4,850USD£3,678GBP
- Report
- April 2025
- 150 Pages
Global
From €4297EUR$4,850USD£3,678GBP

The Gastrointestinal Drugs market is a sector of the pharmaceutical industry that focuses on the development and production of drugs used to treat diseases and disorders of the gastrointestinal tract. These drugs are used to treat conditions such as irritable bowel syndrome, Crohn's disease, ulcerative colitis, and gastroesophageal reflux disease. Commonly prescribed drugs include antacids, proton pump inhibitors, and H2 receptor antagonists.
The Gastrointestinal Drugs market is highly competitive, with many large pharmaceutical companies vying for market share. Some of the major players in the market include Pfizer, GlaxoSmithKline, Merck & Co., AstraZeneca, and Novartis. These companies are constantly developing new drugs and treatments to meet the needs of patients. Show Less Read more